Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference
NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, an emerging biopharmaceutical company developing Natural Killer Cell Therapeutics, today...
Staff
SpringWorks Therapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
- Enrollment Complete in the Phase 3 DeFi Trial of Nirogacestat in Adult Patients with Desmoid Tumors - - Clinical...
Sol-Gel Technologies Reports Third Quarter 2020 Financial Results and Corporate Update
Epsolay® PDUFA goal date set for April 26, 2021 Twyneo® New Drug Application submitted to the U.S. FDA Top-line generic...
Correction: Interim report 2020-01-01 to 2020-09-30
Press release (MAR) Malmö, November 12, 2020 Correction: Interim report 2020-01-01 to 2020-09-30 In the interim report that Acarix submitted...
iTeos Reports Third Quarter 2020 Financial Results and Provides Business Update
- Patient enrollment in Phase 1/2 studies of EOS-850 A2AR antagonist and EOS-448 FCγR-enabled anti-TIGIT antibody continues with initial data...
Nabriva Therapeutics to Participate in Upcoming Virtual Investor Conferences
DUBLIN, Ireland, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization...
COMPASS Pathways plc announces financial results for third quarter 2020
Highlights include $146.6 million IPO, continued progress with phase IIb psilocybin therapy clinical trial, strengthened board and leadership team, and...
Surrozen to Present at the Stifel 2020 Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Surrozen Inc., a biotechnology company pioneering a new class of...
iTeos Appoints Matthew Roden, Ph.D. to Board of Directors
CAMBRIDGE, Mass. and GOSSELIES, Belgium, Nov. 12, 2020 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical company...
BioCryst to Present Data at the 2020 ASH Annual Meeting
RESEARCH TRIANGLE PARK, N.C., Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that preclinical data...
Zentalis Pharmaceuticals to Participate In Two Upcoming Investor Conferences
NEW YORK and SAN DIEGO, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company...
Allscripts Client Experience Event Connects Thousands of Attendees Virtually From Around the World
Company provided more than 135 online sessions, sharing 60 hours of content and raising funds to support efforts to end...
DJO® Acquires STAR® Ankle and Finger Arthroplasty Systems
Acquisition adds two new and rapidly growing segments to surgical portfolio DALLAS--(BUSINESS WIRE)--DJO, LLC (DJO or the Company), a leading...
Talaris Therapeutics Expands Leadership Team With Appointments of Accomplished Executives in Manufacturing, Portfolio Strategy and Clinical Operations
BOSTON & LOUISVILLE, Ky.--(BUSINESS WIRE)--Talaris Therapeutics, Inc., a privately held biotechnology company developing transformative cell therapies that have the potential...
Evotec Expands Oxfordshire Site into a Fully-Integrated R&D Centre Named ‘Dorothy Crowfoot Hodgkin Campus’
CREATES UNIQUE CO-LOCATED, FULLY-INTEGRATED, HIGH-CAPACITY R&D CENTRE ADDS IN VITRO PHARMACOLOGY AND EXPANDS PROTEIN SCIENCES CREATES CENTRE OF EXCELLENCE FOR...
Evotec SE Reports Results For the First Nine Months 2020 and Provides Corporate Update
MULTIPLE NEW & EXTENDED DRUG DISCOVERY AND DEVELOPMENT ALLIANCES; VERY GOOD PROGRESS IN CO-OWNED PIPELINE INCREASING MOMENTUM DESPITE DIFFICULT BUSINESS...
Glaukos Announces Participation in Upcoming Investor Conferences
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...
Outset Medical Reports Third Quarter 2020 Financial Results
Strong Quarter Driven by Accelerating Acute Market Penetration and Significant Margin Expansion SAN JOSE, Calif.--(BUSINESS WIRE)--Outset Medical, Inc. (Nasdaq: OM)...
LENSAR Announces Presentations at American Academy of Ophthalmology Highlighting the Advantages of Streamline IV in Both Cataract and Astigmatism Corrective Surgery
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on femtosecond laser surgical...
MorphoSys and Cherry Biolabs Announce Licensing of Hemibody Technology
The parties signed a multi-target exclusive licensing agreement for application of Cherry Biolabs' Hemibody technology Combination with MorphoSys' antibody know-how...